You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: February 9, 2025

Drugs with Dosage: GRANULES


✉ Email this page to a colleague

« Back to Dashboard


Drugs with Dosage: GRANULES

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration Dosage
Novartis VIJOICE alpelisib GRANULES;ORAL 218466-001 Apr 24, 2024 RX Yes Yes ⤷  Free Trial ⤷  Free Trial Y Y ⤷  Free Trial GRANULES;ORAL
Novartis VIJOICE alpelisib GRANULES;ORAL 218466-001 Apr 24, 2024 RX Yes Yes ⤷  Free Trial ⤷  Free Trial Y Y ⤷  Free Trial GRANULES;ORAL
Vertex Pharms Inc TRIKAFTA (COPACKAGED) elexacaftor, ivacaftor, tezacaftor; ivacaftor GRANULES;ORAL 217660-001 Apr 26, 2023 RX Yes No ⤷  Free Trial ⤷  Free Trial ⤷  Free Trial GRANULES;ORAL
Vertex Pharms Inc TRIKAFTA (COPACKAGED) elexacaftor, ivacaftor, tezacaftor; ivacaftor GRANULES;ORAL 217660-001 Apr 26, 2023 RX Yes No ⤷  Free Trial ⤷  Free Trial ⤷  Free Trial GRANULES;ORAL
Vertex Pharms Inc TRIKAFTA (COPACKAGED) elexacaftor, ivacaftor, tezacaftor; ivacaftor GRANULES;ORAL 217660-001 Apr 26, 2023 RX Yes No ⤷  Free Trial ⤷  Free Trial ⤷  Free Trial GRANULES;ORAL
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration >Dosage

Market Dynamics and Financial Trajectory of Pharmaceutical Drugs Dosed by Granules

Introduction

The pharmaceutical industry is undergoing significant transformations, driven by advances in drug formulation, changing market dynamics, and evolving patient needs. One of the noteworthy developments in this sector is the rise of pharmaceutical granules, particularly pharmaceutical pellets, which are revolutionizing drug delivery systems. Here, we delve into the market dynamics and financial trajectory of pharmaceutical drugs dosed by granules.

The Rise of Pharmaceutical Pellets

Pharmaceutical pellets are small, spherical or cylindrical granules containing active pharmaceutical ingredients (APIs), designed for controlled or targeted drug release. These pellets offer several advantages over conventional tablets and capsules, including precise control over drug release, improved efficacy, reduced side effects, and enhanced patient compliance[3].

Market Growth and Drivers

The market for pharmaceutical pellets is anticipated to grow significantly in the coming years. Key drivers include the rising need for more accurate and potent medications, especially for chronic conditions and diseases requiring continuous drug administration. The growing demand for patient-centric drug delivery systems and the increasing adoption of advanced healthcare technologies in emerging markets are also fueling this growth[3].

Geographic Trends

North America currently dominates the pharmaceutical pellets market due to the presence of major pharmaceutical companies and advanced healthcare infrastructure. However, the Asia-Pacific region is expected to witness the highest growth rate, driven by rising healthcare investments, improving economic conditions, and the growing adoption of advanced drug delivery systems[3].

Therapeutic Applications

Pharmaceutical pellets are crucial in various therapeutic areas such as oncology, cardiology, neurology, and gastroenterology, where controlled drug release is vital for patient outcomes. The versatility of these pellets in treating pediatric, geriatric, and other special populations further expands their market potential[3].

Financial Trajectory

The financial performance of companies involved in the production of pharmaceutical pellets is influenced by several factors.

Revenue Growth

Companies like Servier Group have shown significant revenue growth, driven by the sales of brand-name and generic medicines. For the 2022-2023 financial year, Servier's consolidated revenue increased by 9.2%, with brand-name medicines contributing €4.041 billion and generics contributing €1.286 billion[2].

Investment Opportunities

The growing demand for efficient drug delivery solutions has opened several investment opportunities in the pharmaceutical pellets market. Investors are increasingly looking for high-growth segments, and pharmaceutical pellets offer a wealth of potential. However, challenges such as the high cost of pellet production and regulatory hurdles need to be addressed[3].

Cost and Revenue Dynamics

The development and production of pharmaceutical drugs, including those dosed by granules, involve substantial costs. The average out-of-pocket costs to develop one drug can range from $280 to $380 million, while the total cost, including capital costs for drugs that fail to reach the market, can be as high as $2.4 to $3.2 billion[5].

Challenges and Mitigation Strategies

Despite the promising future of pharmaceutical pellets, several challenges must be overcome.

High Production Costs

The high cost of pellet production is a significant barrier. However, ongoing research and the development of cost-effective manufacturing technologies are expected to mitigate these costs over time[3].

Regulatory Hurdles

Regulatory challenges also pose a risk to the growth of the pharmaceutical pellets market. Companies must navigate complex regulatory environments to ensure compliance and approval for their products[3].

Specialized Expertise

The complexity of pellet formulation requires specialized expertise, which may limit the number of players in the market. Collaborations and investments in research and development can help address this issue[3].

Market Trends and Innovations

The pharmaceutical industry is witnessing a profound transformation driven by external forces and internal dynamics.

Innovations in Drug Delivery

Novel drug delivery methods, including pharmaceutical pellets, are at the forefront of innovation in the pharmaceutical sector. These advancements are driven by the need for precision in treatment and the rise of personalized medicine[3].

Data and Digital Technology

The ability of R&D systems to leverage data and digital technology advances is crucial for informing innovative clinical trial designs and driving scientific and medical advancements. This integration of technology is expected to enhance the efficiency and efficacy of drug development[5].

Global Market Expansion

Improving access to healthcare in emerging markets is supporting the growth of the pharmaceutical industry, including the segment focused on granules. The Asia Pacific region, in particular, is expected to drive global output and sales growth in the pharmaceutical sector[1].

Key Players and Strategies

Companies in the pharmaceutical industry are adopting various strategies to address current trends and challenges.

Servier Group's Ambition

Servier Group, for example, has set ambitious targets for 2025, including reaching €6 billion in revenue and an EBITDA of €1.3 billion. The group's performance is driven by the growth in sales volumes of brand-name and generic medicines worldwide[2].

Addressing Industry Trends

To address the current pharma industry trends, companies are focusing on strategies such as managing downward price pressure, navigating declining M&A deal values, and addressing data governance challenges. These strategies are crucial for translating the potential in their data into reality and maintaining competitive edge[4].

Future Outlook

The future of the pharmaceutical pellets market looks promising, driven by innovations in drug delivery systems, increasing demand for personalized medicine, and the continuous expansion of healthcare markets worldwide.

Advanced Drug Delivery Systems

Pharmaceutical pellets are expected to become even more advanced in terms of design and functionality, with enhanced drug release control mechanisms and better bioavailability. This will further improve patient outcomes and compliance[3].

Investment and Growth

As pharmaceutical companies and investors focus on delivering more effective and convenient treatments, the market for pharmaceutical pellets will continue to grow. This growth will contribute to the overall evolution of the drug delivery landscape and offer significant business and investment opportunities[3].

Key Takeaways

  • Market Growth: The pharmaceutical pellets market is expected to grow significantly, driven by the need for precise and potent medications.
  • Geographic Trends: North America dominates the market, but the Asia-Pacific region is expected to witness the highest growth rate.
  • Financial Performance: Companies involved in pharmaceutical pellet production are experiencing revenue growth, with opportunities for further investment.
  • Challenges: High production costs and regulatory hurdles need to be addressed through ongoing research and technological advancements.
  • Innovations: Novel drug delivery methods and the integration of data and digital technology are driving the industry forward.

FAQs

What are pharmaceutical pellets?

Pharmaceutical pellets are small, solid dosage forms containing active pharmaceutical ingredients (APIs), designed for controlled or targeted drug release.

What are the benefits of using pharmaceutical pellets?

Pharmaceutical pellets offer precise control over drug release, improved efficacy, reduced side effects, and enhanced patient compliance, especially for chronic disease management.

Which regions are driving the growth of the pharmaceutical pellets market?

North America currently dominates the market, but the Asia-Pacific region is expected to witness the highest growth rate due to rising healthcare investments and improving economic conditions.

What are the main challenges facing the pharmaceutical pellets market?

High production costs, regulatory hurdles, and the need for specialized expertise are the main challenges facing the pharmaceutical pellets market.

How are technological advancements impacting the pharmaceutical pellets market?

Technological advancements, including the integration of data and digital technology, are enhancing the efficiency and efficacy of drug development and delivery, driving the market forward.

Sources

  1. Atradius, "Pharmaceuticals Industry Trends January 2024"
  2. Servier, "Servier confirms its 2025 trajectory to achieve its 2030 ambition"
  3. Market Research Intellect, "Pharmaceutical Pellets Market Soars with Advances in Drug Formulation and Delivery"
  4. Korn Ferry, "Six Strategies to Address Pharma Industry Trends in 2024"
  5. RAND, "The Financial Ecosystem of Pharmaceutical R&D"

More… ↓

⤷  Free Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.